
### [NCIT:C45194](http://purl.obolibrary.org/obo/NCIT_C45194)
**Label:** Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

**Subclasses:** [NCIT:C138027](http://purl.obolibrary.org/obo/NCIT_C138027) (Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), [NCIT:C138028](http://purl.obolibrary.org/obo/NCIT_C138028) (Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type), 

**Class expressions from DL-Learner:**

- [NCIT:C38174](http://purl.obolibrary.org/obo/NCIT_C38174) (IRF4/MUM1 Messenger RNA Overexpression) 60.00%
- [NCIT:C38173](http://purl.obolibrary.org/obo/NCIT_C38173) (BCL2 Gene mRNA Overexpression) 60.00%
- [NCIT:C37014](http://purl.obolibrary.org/obo/NCIT_C37014) (Neoplastic Centroblast) 60.00%
- [NCIT:C27213](http://purl.obolibrary.org/obo/NCIT_C27213) (t(14;18)(q32;q21)) 60.00%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C37011](http://purl.obolibrary.org/obo/NCIT_C37011) (Plasmablastic Immunoblast))) 60.00%
- Thing 52.27%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38759](http://purl.obolibrary.org/obo/NCIT_C38759) (EBV Infection))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38732](http://purl.obolibrary.org/obo/NCIT_C38732) (Defective Alpha Heavy Chain Present))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38731](http://purl.obolibrary.org/obo/NCIT_C38731) (Villous Atrophy))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38730](http://purl.obolibrary.org/obo/NCIT_C38730) (Lymphoepithelial Lesion))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38727](http://purl.obolibrary.org/obo/NCIT_C38727) (Villous Lymphocyte))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38721](http://purl.obolibrary.org/obo/NCIT_C38721) (Nuclear Pleomorphism))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C38710](http://purl.obolibrary.org/obo/NCIT_C38710) (Defective Gamma Heavy Chain Present))) 45.36%
- [NCIT:C37010](http://purl.obolibrary.org/obo/NCIT_C37010) (Neoplastic B-Immunoblast) and (not ([NCIT:C3870](http://purl.obolibrary.org/obo/NCIT_C3870) (Lymphangitic Carcinomatosis))) 45.36%


